149 related articles for article (PubMed ID: 21645640)
1. Common symptoms and stressors among individuals with inflammatory bowel diseases.
Singh S; Blanchard A; Walker JR; Graff LA; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2011 Sep; 9(9):769-75. PubMed ID: 21645640
[TBL] [Abstract][Full Text] [Related]
2. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.
Clara I; Lix LM; Walker JR; Graff LA; Miller N; Rogala L; Rawsthorne P; Bernstein CN
Am J Gastroenterol; 2009 Jul; 104(7):1754-63. PubMed ID: 19455122
[TBL] [Abstract][Full Text] [Related]
3. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life.
Graff LA; Walker JR; Lix L; Clara I; Rawsthorne P; Rogala L; Miller N; Jakul L; McPhail C; Ediger J; Bernstein CN
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1491-1501. PubMed ID: 17162241
[TBL] [Abstract][Full Text] [Related]
4. A prospective population-based study of triggers of symptomatic flares in IBD.
Bernstein CN; Singh S; Graff LA; Walker JR; Miller N; Cheang M
Am J Gastroenterol; 2010 Sep; 105(9):1994-2002. PubMed ID: 20372115
[TBL] [Abstract][Full Text] [Related]
5. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls.
Graff LA; Walker JR; Clara I; Lix L; Miller N; Rogala L; Rawsthorne P; Bernstein CN
Am J Gastroenterol; 2009 Dec; 104(12):2959-69. PubMed ID: 19755973
[TBL] [Abstract][Full Text] [Related]
6. Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors.
Graff LA; Clara I; Walker JR; Lix L; Carr R; Miller N; Rogala L; Bernstein CN
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1140-6. PubMed ID: 23602816
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal symptoms before and during menses in women with IBD.
Bernstein MT; Graff LA; Targownik LE; Downing K; Shafer LA; Rawsthorne P; Bernstein CN; Avery L
Aliment Pharmacol Ther; 2012 Jul; 36(2):135-44. PubMed ID: 22621660
[TBL] [Abstract][Full Text] [Related]
8. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
9. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
[TBL] [Abstract][Full Text] [Related]
10. Stressful life events as a risk factor for inflammatory bowel disease onset: A population-based case-control study.
Lerebours E; Gower-Rousseau C; Merle V; Brazier F; Debeugny S; Marti R; Salomez JL; Hellot MF; Dupas JL; Colombel JF; Cortot A; Benichou J
Am J Gastroenterol; 2007 Jan; 102(1):122-31. PubMed ID: 17100973
[TBL] [Abstract][Full Text] [Related]
11. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
13. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
[TBL] [Abstract][Full Text] [Related]
14. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
15. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
Bernstein CN; Blanchard JF; Metge C; Yogendran M
Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
[TBL] [Abstract][Full Text] [Related]
16. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
[TBL] [Abstract][Full Text] [Related]
17. Previous experience and quiality of life in patients with inflammatory bowel disease during relapse.
Casellas F; López Vivancos J; Malagela JR
Rev Esp Enferm Dig; 2003 Jul; 95(7):476-9, 471-5. PubMed ID: 12952508
[TBL] [Abstract][Full Text] [Related]
18. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
[TBL] [Abstract][Full Text] [Related]
19. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
20. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
